title: Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
abstract: The aim of this study was to assess cellular proliferation using silver-stained nucleolar organizer regions (AgNOR) and the proliferating cell nuclear antigen (PCNA) in various tissues in the prostate of ram lambs implanted with increasing zeranol doses and to compare the sensitivity of different tissues of lamb prostate to zeranol. Twenty-four Akkaraman lambs were implanted with increasing zeranol doses, including 12 mg (n = 8), 24 mg (n = 8) and 96 mg (n = 8), with eight lambs serving as controls. After 33 days, the prostate tissues of the lambs were stained using AgNOR and PCNA techniques. The prostate tissues were divided into two compartments--the epithelial tissues, including glandular acinus, collecting duct and penile urethra, and the non-epithelial tissues, including interstitial tissue and striated muscle. AgNOR dots and PCNA index on each prostatic tissue were counted under a light microscope and were evaluated statistically. AgNOR staining in the treatment groups showed a higher score in the non-epithelial tissues than the epithelial components, whereas the PCNA index was significant in the epithelial tissues and non-epithelial tissues had very low PCNA immunostaining. According to the PCNA index, collecting duct epithelium showed more sensitivity to increasing zeranol doses and according to AgNOR counts, there was no difference of sensitivity to zeranol among tissues of the same origin. Both AgNOR counts and PCNA indexes seem to be valuable proliferating markers for the epithelial components of ram prostate, but PCNA index had no significance in relation to the non-epithelial components in contrast to AgNOR counts. Therefore, the controversial results arising from the combined use of both techniques as proliferating markers for the ram prostate should be considered in further studies.
authors.affiliation: Department of Pathology, Faculty of Veterinary Medicine, University of Ondokuz Mayis, Kurupelit, Samsun, Turkey. mygulbahar@hotmail.com
authors.forename: M Y
authors.initials: MY
authors.lastname: Gulbahar
authors.forename: H
authors.initials: H
authors.lastname: Yuksel
authors.forename: T
authors.initials: T
authors.lastname: Guvenc
authors.forename: H
authors.initials: H
authors.lastname: Okut
mesh_terms: D000818:Animals; D002455:Cell Division; D004305:Dose-Response Relationship, Drug; D004343:Drug Implants; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology*; D007150:Immunohistochemistry / Q000662:veterinary; D008297:Male; D009697:Nucleolus Organizer Region / Q000473:pathology*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis*; D011467:Prostate / Q000166:cytology* / Q000187:drug effects / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary; D011897:Random Allocation; D012756:Sheep; D012757:Sheep Diseases / Q000139:chemically induced / Q000473:pathology; D016622:Silver Staining / Q000662:veterinary; D013194:Staining and Labeling / Q000662:veterinary; D015029:Zeranol / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D004343:Drug Implants; D004968:Estrogens, Non-Steroidal; D018809:Proliferating Cell Nuclear Antigen; D015029:Zeranol